[SAN FRANCISCO, USA – May 12th 2025] The animal longevity industry is achieving unprecedented breakthroughs, according to a new 350-page ClearView Market Insights report. The market is projected to grow at a CAGR of 33.7%, reaching USD 22.6 billion by 2032, thus redefining pet lifespans.

Request Sample @ https://clearviewmarketinsights.com/report-details/animal-longevity-medicine/

Key Industry Shifts

1. Clinical Validation

• LOY-002 Trial Results:
• 28% lower mortality in senior dogs
• 1.8 year median lifespan extension
• Telomerase Therapy:
• Restores immune function in aging canines

2. Economic Impacts

• Pet Owner Spending:
• Average $2,800/year on longevity regimens
• Insurance Premiums:
• 22% lower for treated animals

3. Mainstream Adoption

• Veterinary Protocols:
• 60% of AAHA clinics now offer longevity panels
• Consumer Demand:
• Waitlists exceed 18 months at specialty centers

Executive Insights

• Celine Halioua, Loyal CEO:
  "We're not just adding years to life—we're adding life to years."
• Daniel Oliver, Rejuvenate Bio:
  "Our gene therapy essentially resets the aging clock."

Future Projections

• 2028: First FDA approval for lifespan extension
• 2030: Routine epigenetic reset at middle age
• 2032: 25% of senior pets on treatment

For more insights, visit https://clearviewmarketinsights.com/report-store

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369